Whitepapers
Modeling Excipient Selection's Impact on Nitros...
Risk control for nitrosamine impurities in drug products is a major challenge in the industry. Nitrosamines can form during drug product manufacturing and storage through the reaction of nitrites with...
Modeling Excipient Selection's Impact on Nitros...
Risk control for nitrosamine impurities in drug products is a major challenge in the industry. Nitrosamines can form during drug product manufacturing and storage through the reaction of nitrites with...
New Standards in Visible Particle Detection in ...
Visible particles in pharmaceutical powder excipients are typically counted manually. However, because the human eye’s ability to detect particles is subjective, manual counting is prone to operator-dependent bias and potential...
New Standards in Visible Particle Detection in ...
Visible particles in pharmaceutical powder excipients are typically counted manually. However, because the human eye’s ability to detect particles is subjective, manual counting is prone to operator-dependent bias and potential...
Nitrosamines Risk Mitigation: The critical role...
Evaluating nitrosamines in drug products has become a big challenge for formulators in the pharmaceutical industry. When excipients are considered as a potential risk factor during the drug product risk assessment,...
Nitrosamines Risk Mitigation: The critical role...
Evaluating nitrosamines in drug products has become a big challenge for formulators in the pharmaceutical industry. When excipients are considered as a potential risk factor during the drug product risk assessment,...